Professor Muller earned her doctorate in sciences at the University of Strasbourg and focused on immune responses as a postdoctoral researcher at the Max Planck Institute for Immunobiology in Freiburg. Today, Prof. Muller is a research director at CNRS and supervises over 50 researchers at the CNRS Laboratory of Therapeutic Immunology and Chemistry at the Institute of Molecular and Cellular Biology in Strasbourg, which she has headed since 2001. She is also Head and Coordinator of the Drug Discovery Center for Cancer and Inflammation. Her expertise in peptide immunochemistry, combined with insights into the molecular and cellular pathways behind autoimmune disease, led to the discovery of Lupuzor. Professor Muller has filed for 24 patents and published more than 330 papers and reviews. For her contributions to the treatment and understanding of immune-inflammatory diseases, Professor Muller has received numerous awards, including the Apollo-B award from Roche (2007), the CNRS Silver Medal (2010), the CNRS Innovation Medal (2015) and the French Académie des Sciences Grand Prix Léon Velluz (2016). Professor Muller was also a founder of Neosystem, now Polypeptide-France, a leading peptide development and manufacturing company. She is the key inventor of ImmuPharma’s lead drug candidate Lupuzor™, for Lupus, and has been working in this field for more than ten years. Professor Muller earned her doctorate in sciences at the University of Strasbourg and focused on immune responses as a postdoctoral researcher at the Max Planck Institute for Immunobiology in Freiburg. Today, Prof. Muller is a research director at CNRS and supervises over 50 researchers at the CNRS Laboratory of Therapeutic Immunology and Chemistry at the Institute of Molecular and Cellular Biology in Strasbourg, which she has headed since 2001. She is also Head and Coordinator of the Drug Discovery Center for Cancer and Inflammation. Her expertise in peptide immunochemistry, combined with insights into the molecular and cellular pathways behind autoimmune disease, led to the discovery of Lupuzor. Professor Muller has filed for 24 patents and published more than 330 papers and reviews. For her contributions to the treatment and understanding of immune-inflammatory diseases, Professor Muller has received numerous awards, including the Apollo-B award from Roche (2007), the CNRS Silver Medal (2010), the CNRS Innovation Medal (2015) and the French Académie des Sciences Grand Prix Léon Velluz (2016). Professor Muller was also a founder of Neosystem, now Polypeptide-France, a leading peptide development and manufacturing company. She is the key inventor of ImmuPharma’s lead drug candidate Lupuzor™, for Lupus, and has been working in this field for more than ten years.

Radiology, Oncology, Cancer research